198 related articles for article (PubMed ID: 1487408)
1. Phase II study of gemcitabine in advanced colorectal adenocarcinoma.
Moore DF; Pazdur R; Daugherty K; Tarassoff P; Abbruzzese JL
Invest New Drugs; 1992 Nov; 10(4):323-5. PubMed ID: 1487408
[TBL] [Abstract][Full Text] [Related]
2. A phase I trial of weekly gemcitabine administered as a prolonged infusion in patients with pancreatic cancer and other solid tumors.
Brand R; Capadano M; Tempero M
Invest New Drugs; 1997; 15(4):331-41. PubMed ID: 9547676
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of 150-minute weekly infusion of gemcitabine in advanced colorectal cancer: minimal activity in colorectal cancer.
Mani S; Kugler JW; Knost JA; Sciortino DF; Gibbons J; Garcia JC; Ansari RH; Schilsky RL; Vokes EE
Invest New Drugs; 1998-1999; 16(3):275-8. PubMed ID: 10360609
[TBL] [Abstract][Full Text] [Related]
4. Concurrent infusional gemcitabine and radiation in the treatment of advanced unresectable GI malignancy: a phase I study.
Mohiuddin M; Kudrimoti M; Regine WF; McGrath PC; Hanna N; John W
Cancer J; 2002; 8(3):255-62. PubMed ID: 12074325
[TBL] [Abstract][Full Text] [Related]
5. Cancer and leukemia group B (CALGB) 89805: phase II chemoradiation trial using gemcitabine in patients with locoregional adenocarcinoma of the pancreas.
Blackstock AW; Tepper JE; Niedwiecki D; Hollis DR; Mayer RJ; Tempero MA
Int J Gastrointest Cancer; 2003; 34(2-3):107-16. PubMed ID: 15361643
[TBL] [Abstract][Full Text] [Related]
6. A phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer.
Ikeda M; Okada S; Tokuuye K; Ueno H; Okusaka T
Br J Cancer; 2002 May; 86(10):1551-4. PubMed ID: 12085203
[TBL] [Abstract][Full Text] [Related]
7. Phase II studies of gemcitabine for non-small cell lung cancer in Japan.
Fukuoka M; Takada M; Yokoyama A; Kurita Y; Niitani H
Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-42-S7-46. PubMed ID: 9194479
[TBL] [Abstract][Full Text] [Related]
8. Clinical results of a pharmacodynamically-based strategy for higher dosing of gemcitabine in patients with solid tumors.
Touroutoglou N; Gravel D; Raber MN; Plunkett W; Abbruzzese JL
Ann Oncol; 1998 Sep; 9(9):1003-8. PubMed ID: 9818075
[TBL] [Abstract][Full Text] [Related]
9. Prolonged infusion of gemcitabine in stage IV breast cancer: a phase I study.
Akrivakis K; Schmid P; Flath B; Schweigert M; Sezer O; Mergenthaler HG; Possinger K
Anticancer Drugs; 1999 Jul; 10(6):525-31. PubMed ID: 10885899
[TBL] [Abstract][Full Text] [Related]
10. Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer.
Fossella FV; Lippman SM; Shin DM; Tarassoff P; Calayag-Jung M; Perez-Soler R; Lee JS; Murphy WK; Glisson B; Rivera E; Hong WK
J Clin Oncol; 1997 Jan; 15(1):310-6. PubMed ID: 8996158
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine in patients with advanced malignant melanoma or gastric cancer: phase II studies of the EORTC Early Clinical Trials Group.
Sessa C; Aamdal S; Wolff I; Eppelbaum R; Smyth JF; Sulkes A; Ten Bokkel Huinink W; Vermorken J; Wanders J; Franklin H
Ann Oncol; 1994 May; 5(5):471-2. PubMed ID: 8075055
[TBL] [Abstract][Full Text] [Related]
12. Phase I study of twice-weekly gemcitabine and concomitant external-beam radiotherapy in patients with adenocarcinoma of the pancreas.
Pipas JM; Mitchell SE; Barth RJ; Vera-Gimon R; Rathmann J; Meyer LP; Wagman RS; Lewis LD; McDonnell C; Colacchio TA; Perez RP
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1317-22. PubMed ID: 11483344
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of gemcitabine in patients with advanced gastric cancer.
Christman K; Kelsen D; Saltz L; Tarassoff PG
Cancer; 1994 Jan; 73(1):5-7. PubMed ID: 8275437
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer.
Shepherd FA; Cormier Y; Burkes R; Evans WK; Goss G; Klimo P; Feld R; Taylor M
Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-27-S8-30. PubMed ID: 9207313
[TBL] [Abstract][Full Text] [Related]
15. Gemcitabine in the second-line therapy of patients with carcinoma of unknown primary site: a phase II trial of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Burris HA; Calvert SW; Willcutt NT; Scullin DC; Bramham J; Greco FA
Cancer Invest; 2001; 19(4):335-9. PubMed ID: 11405172
[TBL] [Abstract][Full Text] [Related]
16. Gemcitabine: a phase II study in patients with advanced renal cancer.
De Mulder PH; Weissbach L; Jakse G; Osieka R; Blatter J
Cancer Chemother Pharmacol; 1996; 37(5):491-5. PubMed ID: 8599874
[TBL] [Abstract][Full Text] [Related]
17. A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinoma.
Ulrich-Pur H; Kornek GV; Raderer M; Haider K; Kwasny W; Depisch D; Greul R; Schneeweiss B; Krauss G; Funovics J; Scheithauer W
Cancer; 2000 Jun; 88(11):2505-11. PubMed ID: 10861426
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of gemcitabine in patients with previously untreated metastatic cancer of the esophagus or gastroesophageal junction.
Sandler AB; Kindler HL; Einhorn LH; Mitchell E; Masters G; Kraut M; Nicol S; Raghavan D
Ann Oncol; 2000 Sep; 11(9):1161-4. PubMed ID: 11061612
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of gemcitabine (2,2'-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas.
Casper ES; Green MR; Kelsen DP; Heelan RT; Brown TD; Flombaum CD; Trochanowski B; Tarassoff PG
Invest New Drugs; 1994; 12(1):29-34. PubMed ID: 7960602
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) in previously treated ovarian cancer patients.
Lund B; Hansen OP; Theilade K; Hansen M; Neijt JP
J Natl Cancer Inst; 1994 Oct; 86(20):1530-3. PubMed ID: 7932808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
